Results 271 to 280 of about 804,384 (336)
Some of the next articles are maybe not open access.
Combined‐modality therapy for gastric cancer
Seminars in Surgical Oncology, 2003AbstractGastric cancer has a poor prognosis. It is often diagnosed at an advanced stage, and potentially curative treatments often can not be exercised. Even when a curative surgical resection is possible, only a minority of patients survive beyond 5 years, and locoregional failures are frequent among patients undergoing curative resections.
James C, Yao +6 more
openaire +2 more sources
Combined modality therapy for pancreatic cancer
Seminars in Oncology, 2003In spite of the high mortality in pancreatic cancer, significant progress is being made. This review discusses multimodality therapy for patients with pancreatic cancer. According to several phase II trials and Gastrointestinal Tumor Study Group results, improvements in locoregional control and survival may be achieved when chemotherapy is added to ...
James Y, Tsai +2 more
openaire +2 more sources
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale Experience. [PDF]
Journal of Clinical Oncology, 1986 In the article by Koletsky et al "Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy—The Yale Experience" (Journal of Clinical Oncology 4:311–317, 1986), an error was made in the footnote on page 311 which described ...
A. Koletsky +6 more
semanticscholar +2 more sources
Combined modality therapy of esophageal carcinoma
Cancer, 1981One hundred ten patients with epidermoid carcinoma of the esophagus were treated at the Memorial Sloan-Kettering Cancer Center (MSKCC) with combined modality techniques involving preoperative irradiation (RT) and surgery, and with preoperative chemotherapy (CT), surgery, and irradiation.
D P, Kelsen +7 more
openaire +2 more sources
Combined Modality Therapy of Gastric Cancer
Surgical Oncology Clinics of North America, 1997Most patients with adenocarcinoma of the stomach continue to present with advanced stages of disease. Although cure is not possible without complete resection, most patients will go on to recur and die of their disease. Despite the efforts of the last 3 to 4 decades, little progress has been made in improving disease specific survival.
M S, Karpeh, D P, Kelsen
openaire +2 more sources
Combined Modality Therapy for Rectal Cancer
The Cancer Journal, 2016The primary therapy for any potentially curative rectal cancer is surgery. For locally advanced tumors (i.e., T3-4 and/or node positive), the very high rate of local and distant recurrences has necessitated a standard adjuvant regimen of preoperative chemoradiation and postoperative chemotherapy.
Sagar A, Patel +2 more
openaire +2 more sources
Combined modality therapy for gynecologic cancer
Current Opinion in Oncology, 1995The use of combined modality therapy in the primary management of gynecologic cancer continues to be explored. Although early ovarian cancer is treated with postoperative adjuvant treatment, the data to support its value is lacking. In advanced disease, paclitaxel has emerged as the most optimal treatment after maximal cytoreduction.
I, Ackerman, G M, Thomas
openaire +2 more sources
Combined modality therapy for esophageal cancer
Current Oncology Reports, 1999Whereas many patients with esophageal carcinoma present with what appears to be localized disease, cure rates with surgical resection alone remain low. Although surgical resection, where feasible, affords patients the best chance of cure, the primary tumor has often invaded local tissues or structures, and occult micrometastases often exist at the time
Z, Gamliel, M J, Krasna
openaire +2 more sources
Combined Modality Therapy in the Elderly Population
Current Treatment Options in Oncology, 2009The incidence of cancer among older patients continues to rise. The use of combined modality therapy has improved survival in a variety of malignancies, including rectal, head and neck, and lung cancer; however, the addition of chemotherapy increases substantially the toxicities of treatment.
Lilie L, Lin, Stephen M, Hahn
openaire +2 more sources
Combined Modality Therapy for Rectal Cancer
The Cancer Journal, 2010The standard adjuvant treatment for cT3 and/or N+ rectal cancer is preoperative chemoradiation. However, there are many controversies regarding this approach. These include the role of short course radiation, whether postoperative adjuvant chemotherapy necessary for all patients and whether the type of surgery after chemoradiation should be based on ...
Minsky, Bd +2 more
openaire +3 more sources